FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.
Francis RE, Myatt SS, Krol J, Hartman J, Peck B, McGovern UB, Wang J, Guest SK, Filipovic A, Gojis O, Palmieri C, Peston D, Shousha S, Yu Q, Sicinski P, Coombes RC, Lam EW.
Francis RE, et al. Among authors: coombes rc.
Int J Oncol. 2009 Jul;35(1):57-68. doi: 10.3892/ijo_00000313.
Int J Oncol. 2009.
PMID: 19513552
Free PMC article.